Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Alam M, Ratner D (2001) Cutaneous squamous-cell carcinoma. N Engl J Med 344:975–983
Staples MP, Elwood M, Burton RC, et al (2006) Non-melanoma skin cancer in Australia: the 2002 national survey and trends since 1985. Med J Aust 184:6–10
Brewster DH, Bhatti LA, Inglis JH, et al (2007) Recent trends in incidence of nonmelanoma skin cancers in the East of Scotland, 1992–2003. Br J Dermatol 156:1295–1300
Hayes RC, Leonfellner S, Pilgrim W, et al (2007) Incidence of nonmelanoma skin cancer in New Brunswick, Canada, 1992 to 2001. J Cutan Med Surg 11:45–52
Stang A, Ziegler S, Buchner U, et al (2007) Malignant melanoma and nonmelanoma skin cancers in Northrhine-Westphalia, Germany: a patient- vs. diagnosis-based incidence approach. Int J Dermatol 46:564–570
Hannuksela-Svahn A, Pukkala E, Karvonen J (1999) Basal cell skin carcinoma and other nonmelanoma skin cancers in Finland from 1956 through 1995. Arch Dermatol 135:781–786
Yang L, Parkin DM, Ferlay J, et al (2005) Estimates of cancer incidence in China for 2000 and projections for 2005. Cancer Epidemiol Biomarkers Prev 14:243–250
Marcil I, Stern RS (2000) Risk of developing a subsequent nonmelanoma skin cancer in patients with a history of non-melanoma skin cancer: a critical review of the literature and meta-analysis. Arch Dermatol 136:1524–1530
Miller DL, Weinstock MA (1994) Nonmelanoma skin cancer in the United States: incidence. J Am Acad Dermatol 30:774–778
Thomas-Ahner JM, Wulff BC, Tober KL, et al (2007) Gender differences in UVB-induced skin carcinogenesis, inflamma-tion, and DNA damage. Cancer Res 67:3468–3474
Weinstock MA (1993) Nonmelanoma skin cancer mortality in the United States, 1969 through 1988. Arch Dermatol 129:1286–1290
Johnson TM, Rowe DE, Nelson BR, et al (1992) Squamous cell carcinoma of the skin (excluding lip and oral mucosa). J Am Acad Dermatol. 26:467–484
Stang A, Jockel KH (2004) Declining mortality rates for nonmelanoma skin cancers in West Germany, 1968–99. Br J Dermatol 150:517–522
Petter G, Haustein UF (2000) Histologic subtyping and malignancy assessment of cutaneous squamous cell carcinoma. Dermatol Surg 26:521–530
English DR, Armstrong BK, Kricker A, et al (1998) Case-control study of sun exposure and squamous cell carcinoma of the skin. Int J Cancer 77:347–353.
Pott P (1775) Chirurgical Works of Percival Pott, F.R.S. and Surgeon to St. Bartholomew's Hospital. Hawes, Clarke, Collins, London
Warnakulasuriya KA, Ralhan R (2007) Clinical, pathological, cellular and molecular lesions caused by oral smokeless tobacco—a review. J Oral Pathol Med 36:63–77
Hoffmann D, Djordjevic MV, Fan J, et al (1995) Five leading U.S. commercial brands of moist snuff in 1994: assessment of carcinogenic N-nitrosamines. J Natl Cancer Inst 87:1862–1869
Gawkrodger DJ (2004) Occupational skin cancers. Occup Med (Lond) 54:458–463
Dinehart SM, Nelson-Adesokan P, Cockerell C, et al (1997) Metastatic cutaneous squamous cell carcinoma derived from actinic keratosis. Cancer 79:920–923
Kwa RE, Campana K, Moy RL (1992) Biology of cutaneous squamous cell carcinoma. J Am Acad Dermatol 26:1–26
Glogau RG (2000) The risk of progression to invasive disease. J Am Acad Dermatol 42:S23–S24
Campbell C, Quinn AG, Ro YS, et al (1993) p53 mutations are common and early events that precede tumor invasion in squamous cell neoplasia of the skin. J Invest Dermatol 100:746–748
Rosen T, Harting M, Gibson M. (2007) Treatment of Bowen's disease with topical 5% imiquimod cream: retrospective study. Dermatol Surg 33:427–431
Guenthner ST, Hurwitz RM, Buckel LJ, et al (1999) Cutaneous squamous cell carcinomas consistently show his-tologic evidence of in situ changes: a clinicopathologic correlation. J Am Acad Dermatol 41:443–448
Karagas MR, Nelson HH, Sehr P, et al (2006) Human papil-lomavirus infection and incidence of squamous cell and basal cell carcinomas of the skin. J Natl Cancer Inst 98:389–395
Masini C, Fuchs PG, Gabrielli F, et al (2003) Evidence for the association of human papillomavirus infection and cutaneous squamous cell carcinoma in immunocompetent individuals. Arch Dermatol 139:890–894
Struijk L, Hall L, van der Meijden E, et al (2006) Markers of cutaneous human papillomavirus infection in individuals with tumor-free skin, actinic keratoses, and squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev 15:529–535
Alam M, Caldwell JB, Eliezri YD (2003) Human papilloma-virus-associated digital squamous cell carcinoma: literature review and report of 21 new cases. J Am Acad Dermatol 48:385–393
Winkelmann RK, Zollman PE, Baldes EJ (1963) Squamous cell carcinoma produced by ultraviolet light in hairless mice. J Invest Dermatol 40:217–224
Ziegler A, Jonason AS, Leffell DJ, et al (1994) Sunburn and p53 in the onset of skin cancer. Nature 372:773–776
Murao K, Kubo Y, Ohtani N, et al (2006) Epigenetic abnormalities in cutaneous squamous cell carcinomas: frequent inactivation of the RB1/p16 and p53 pathways. Br J Dermatol 155:999–1005
Nindl I, Dang C, Forschner T, et al (2006) Identification of differentially expressed genes in cutaneous squamous cell carcinoma by microarray expression profiling. Mol Cancer 5:30
Lohmann CM, Solomon AR (2001) Clinicopathologic variants of cutaneous squamous cell carcinoma. Adv Anat Pathol 8:27–36
Miller SJ, Moresi JM (2003) Actinic keratosis, basal cell carcinoma and squamous cell carcinoma. Dermatology. Mosby, Philadelphia, PA; chap 109
Marjolin JN (1828) Ulcere. In: Adelon NP (ed) Dictionnaire de Medicine, vol 21. Becher, Paris
Sabin SR, Goldstein G, Rosenthal HG, et al (2004) Aggressive squamous cell carcinoma originating as a Marjolin's ulcer. Dermatol Surg 30:229–230
Motley R, Kersey P, Lawrence C, et al (2002) Multiprofessional guidelines for the management of the patient with primary cutaneous squamous cell carcinoma. Br J Dermatol 146:18–25
van der Pols JC, Williams GM, Pandeya N, et al (2006) Prolonged prevention of squamous cell carcinoma of the skin by regular sunscreen use. Cancer Epidemiol Biomarkers Prev 15:2546–2548
Asgari M, White E, Chren MM (2004) Nonsteroidal anti-inflammatory drug use in the prevention and treatment of squamous cell carcinoma. Dermatol Surg 30:1335–1342
Stern RS, Lunder EJ (1998) Risk of squamous cell carcinoma and methoxsalen (psoralen) and UV-A radiation (PUVA). Arch Dermatol 134:1582–1585
Nijsten TE, Stern RS (2003) Oral retinoid use reduces cutaneous squamous cell carcinoma risk in patients with psoriasis treated with psoralen-UVA: a nested cohort study. J Am Acad Dermatol 49:644–650
Chen K, Craig JC, Shumack S (2005) Oral retinoids for the prevention of skin cancers in solid organ transplant recipients: a systematic review of randomized controlled trials. Br J Dermatol 152:518–523
Bouwes Bavinck JN, Euvrard S, Naldi L, et al (2007) Keratotic skin lesions and other risk factors are associated with skin cancer in organ-transplant recipients: a case-control study in The Netherlands, United Kingdom, Germany, France, and Italy. J Invest Dermatol 127:1647–1656
Harwood CA, Leedham-Green M, Leigh IM, et al (2005) Low-dose retinoids in the prevention of cutaneous squamous cell carcinomas in organ transplant recipients: a 16-year retrospective study. Arch Dermatol 141:456–464
Otley CC, Stasko T, Tope WD, et al (2006) Chemoprevention of nonmelanoma skin cancer with systemic retinoids: practical dosing and management of adverse effects. Dermatol Surg 32:562–568
Brown VL, Atkins CL, Ghali L, et al (2005) Safety and effi-cacy of 5% imiquimod cream for the treatment of skin dysplasia in high-risk renal transplant recipients: randomized, double-blind, placebo-controlled trial Arch Dermatol 141:985–993
Perrett CM, McGregor JM, Warwick J, et al (2007) Treatment of post-transplant premalignant skin disease: a randomized intrapatient comparative study of 5-fluorouracil cream and topical photodynamic therapy. Br J Dermatol 156:320–328
Rowe DE, Carroll RJ, Day CL Jr (1992) Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip. Implications for treatment modality selection. J Am Acad Dermatol 26:976–990
Ross AS, Schmults CD (2006) Sentinel lymph node biopsy in cutaneous squamous cell carcinoma: a systematic review of the English literature. Dermatol Surg 32:1309–1321
Martinez JC, Cook JL (2007) High-risk cutaneous squamous cell carcinoma without palpable lymphadenopathy: is there a therapeutic role for elective neck dissection? Dermatol Surg 33:410–420
Sumi M, Ohki M, Nakamura T (2001) Comparison of sonog-raphy and CT for differentiating benign from malignant cervical lymph nodes in patients with squamous cell carcinoma of the head and neck. AJR Am J Roentgenol 176:1019–1024
Cho SB, Chung WG, Yun M, et al (2005) Fluorodeoxyglucose positron emission tomography in cutaneous squamous cell carcinoma: retrospective analysis of 12 patients. Dermatol Surg 31:442–446
Williams LS, Mancuso AA, Mendenhall WM (2001) Perineural spread of cutaneous squamous and basal cell carcinoma: CT and MR detection and its impact on patient management and prognosis. Int J Radiat Oncol Biol Phys 49:1061–1069
Kuflik EG (2004) Cryosurgery for skin cancer: 30-year experience and cure rates. Dermatol Surg 30:297–300
Morrison WH, Garden AS, Ang KK (1997) Radiation therapy for nonmelanoma skin carcinomas. Clin Plast Surg 24:719–729
Braathen LR, Szeimies RM, Basset-Seguin N, et al (2007) Guidelines on the use of photodynamic therapy for nonmela-noma skin cancer: an international consensus. International society for photodynamic therapy in dermatology, 2005. J Am Acad Dermatol 56:125–143
Hengge UR, Schaller J (2004) Successful treatment of invasive squamous cell carcinoma using topical imiquimod. Arch Dermatol 140:404–406
Martin-Garcia RF (2005) Imiquimod: an effective alternative for the treatment of invasive cutaneous squamous cell carcinoma. Dermatol Surg 31:371–374
Peris K, Micantonio T, Fargnoli MC, et al (2006) Imiquimod 5% cream in the treatment of Bowen's disease and invasive squamous cell carcinoma. J Am Acad Dermatol 55:324–327
Drake LA, Dinehart SM, Goltz RW, et al (1995) Guidelines of care for Mohs micrographic surgery. J Am Acad Dermatol 33:271–278
Brodland DG, Zitelli JA (1992) Surgical margins for excision of primary cutaneous squamous cell carcinoma. J Am Acad Dermatol 27:241–248
Rosenthal EL, Kulbersh BD, Duncan RD, et al (2006) In vivo detection of head and neck cancer orthotopic xenografts by immunofluorescence. Laryngoscope. 116:1636–1641
Horn M, Gerger A, Koller S, et al (2007) The use of confocal laser-scanning microscopy in microsurgery for invasive squamous cell carcinoma. Br J Dermatol 156:81–84
Veness MJ, Morgan GJ, Palme CE, et al (2005) Surgery and adjuvant radiotherapy in patients with cutaneous head and neck squamous cell carcinoma metastatic to lymph nodes: combined treatment should be considered best practice. Laryngoscope 115:870–875
Veness MJ, Palme CE, Smith M, et al (2003) Cutaneous head and neck squamous cell carcinoma metastatic to cervical lymph nodes (nonparotid): a better outcome with surgery and adjuvant radiotherapy. Laryngoscope 113:1827–1833
Martinez JC, Otley CC, Okuno SH, et al (2004) Chemotherapy in the management of advanced cutaneous squamous cell carcinoma in organ transplant recipients: theoretical and practical considerations. Dermatol Surg 30:679–686
Brewster AM, Lee JJ, Clayman GL, et al (2007) Randomized trial of adjuvant 13-cis-retinoic acid and interferon alfa for patients with aggressive skin squamous cell carcinoma. J Clin Oncol 25:1974–1978
Annest NM, VanBeek MJ, Arpey CJ, et al (2007) Intralesional methotrexate treatment for keratoacanthoma tumors: a retrospective study and review of the literature. J Am Acad Dermatol 56:989–993
Kurtis B, Rosen T (1980) Treatment of cutaneous neoplasms by intralesional injections of 5-fluorouracil (5-FU). J Dermatol Surg Oncol 6:122–127
Leonard AL, Hanke CW (2006) Treatment of giant keratoa-canthoma with intralesional 5-fluorouracil. J Drugs Dermatol 5:454–456
Parker CM, Hanke CW (1986) Large keratoacanthomas in difficult locations treated with intralesional 5-fluorouracil. J Am Acad Dermatol 14:770–777
Cohen PR, Schulze KE, Teller CF, et al (2005) Intralesional methotrexate for keratoacanthoma of the nose. Skinmed 4:393–395
Melton JL, Nelson BR, Stough DB, et al (1991) Treatment of keratoacanthomas with intralesional methotrexate. J Am Acad Dermatol 25:1017–1023
Donahue B, Cooper JS, Rush S (1990) Treatment of aggressive keratoacanthomas by radiotherapy. J Am Acad Dermatol 23:489–493
Goldschmidt H, Sherwin WK (1993) Radiation therapy of giant aggressive keratoacanthomas. Arch Dermatol 129:1162–1165
Dendorfer M, Oppel T, Wollenberg A, et al (2003) Topical treatment with imiquimod may induce regression of facial keratoacanthoma. Eur J Dermatol 13:80–82
Di Lernia V, Ricci C, Albertini G (2004) Spontaneous regression of keratoacanthoma can be promoted by topical treatment with imiquimod cream. J Eur Acad Dermatol Venereol 18:626–629
Goldberg LH, Rosen T, Becker J, et al (1990) Treatment of solitary keratoacanthomas with oral isotretinoin. J Am Acad Dermatol 23:934–936
Wong WY, Kolbusz RV, Goldberg LH, et al (1994) Treatment of a recurrent keratoacanthoma with oral isotretinoin. Int J Dermatol 33:579–583
Kroon BK, Horenblas S, Nieweg OE (2005) Contemporary management of penile squamous cell carcinoma. J Surg Oncol 89:43–50
Micali G, Nasca MR, Innocenzi D, et al (2006) Penile cancer. J Am Acad Dermatol. 54:369–391
de Hullu JA, van der Avoort IA, Oonk MH, et al (2006) Management of vulvar cancers. Eur J Surg Oncol 32:825–831
Rousseau DL Jr, Thomas CR Jr, Petrelli NJ, et al (2005) Squamous cell carcinoma of the anal canal. Surg Oncol 14:121–132
Kuan YZ, Hsu HC, Kuo TT, et al (2007) Multiple verrucous carcinomas treated with acitretin. J Am Acad Dermatol 56:S29–S32
Schwartz RA (1995) Verrucous carcinoma of the skin and mucosa. J Am Acad Dermatol 32:1–21
Vandeweyer E, Sales F, Deraemaecker R (2001) Cutaneous verrucous carcinoma. Br J Plast Surg 54:168–170
Mullen JT, Feng L, Xing Y, et al (2006) Invasive squamous cell carcinoma of the skin: defining a high-risk group. Ann Surg Oncol 13:902–909
Clayman GL, Lee JJ, Holsinger FC, et al (2005) Mortality risk from squamous cell skin cancer. J Clin Oncol 23:759–765
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Vandergriff, T., Harting, M., Rosen, T. (2010). Invasive Squamous Cell Carcinoma of the Skin. In: Stockfleth, E., Rosen, T., Shumack, S. (eds) Managing Skin Cancer. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-79347-2_5
Download citation
DOI: https://doi.org/10.1007/978-3-540-79347-2_5
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-79346-5
Online ISBN: 978-3-540-79347-2
eBook Packages: MedicineMedicine (R0)